Equity Analysis

Key Financial Ratios
    Zydus Lifesciences Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    532321
    INE010B01027
    177.8674103
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    ZYDUSLIFE
    22.15
    96402.25
    EPS(TTM)
    Face Value()
    Div & Yield %:
    43.26
    1
    0.31
     
   ParticularsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.370.280.250.320.37
Long Term Debt-Equity Ratio0.320.150.030.090.18
Current Ratio2.581.861.381.261.36
Fixed Assets1.301.111.071.151.00
Inventory6.244.714.234.904.43
Debtors2.623.023.753.572.78
Interest Cover Ratio11.858.3012.0227.517.91
PBIDTM (%)47.4632.0626.8030.8735.92
PBITM (%)42.8026.4620.6925.0729.16
PBDTM (%)43.8528.8725.0729.9632.23
CPM (%)36.4723.1120.0926.7929.02
APATM (%)31.8117.5113.9820.9922.26
ROCE (%)22.7313.319.8412.2213.53
RONW (%)23.4511.388.4313.6114.25